Cite
APA Citation
Paturel, C., Anceriz, N., Eyles, J., Lapointe, J., Denis, C., Breso, V., Courtois, R., Augier, S., Brown, L., Luheshi, N., Watkins, A., Cooper, Z., Tu, E., Vivier, E., & Fraenkel, P. (n.d.). 190P Combination of IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, with durvalumab and chemotherapies: Preclinical rationale. Immuno-oncology technology, 16, . http://access.bl.uk/ark:/81055/vdc_100172070375.0x00000f